Waverley Pharma Inc. (TSXV:WAVE)

Healthcare

Waverley Pharma Inc is a healthcare company that focuses on developing, researching, and commercializing oncology-focused human therapeutics in the EU, UK, and North America. For treating cancers, the company provides three products through its subsidiary, including Capecitabine, Temozolomide, and Erlotinib.  

Additionally, it is also developing pemetrexed and bortezomib. Waverley Pharma specializes in delivering cost-effective prescription medicine that helps in lowering healthcare costs.  

It is on a mission to develop and commercialize pharmaceutical products to provide safe and effective therapies. It concentrates on the generic oncology sector in the UK and North America.  

Waverley Pharma Inc is a publicly listed Winnipeg, Canada-based company on the TSX Venture Exchange Market (TSXV), where its common stocks trade under the ticker ‘WAVE’. The company has collaborated with Reliance Life Sciences (RLS), a Mumbai, Indian-based company to commercialize various oncology drugs products for the US and European markets.  

Its various oncology drugs include Temozolomide, Capecitabine, Erlotinib, Bortezomib, and Pemetrexed. Waverley Pharma entered into a binding contract with the U.K. National Health Service for delivering Erlotinib, Temozolomide, and Capecitabine. Its U.S. market oncology drugs are Pemetrexed and WAV-102. 

On September 8, 2020, Waverley Pharma Inc signed a term sheet agreement through its 100 per cent owned subsidiary, Waverley Pharma International Inc, to own and operate exclusive rights to provide six generic oncology products, including WAV-103, WAV-104, WAV-105, WAV-106, WAV-107 and WAV-108 in the US market with Reliance Life Sciences Private Limited. In this agreement, RLS will be responsible for manufacturing and supplying the finished products, while Waverley Pharma will file the Abbreviated New Drug Applications (ANDA) with the United States’ FDA.  

Contact Information

company address 4 - 1250 Waverley Street Winnipeg, Manitoba R3T 6C6

company phone204 928-7900

company email[email protected]

company websitehttps://www.waverleypharma.com/

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK